Understanding Side Effects: What Percentage of People Have Side Effects from Ozempic?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is one of the most effective weight loss medications available today, with clinical trials showing an average weight reduction of 15% over 68 weeks. However, gastrointestinal side effects affect a significant portion of people taking semaglutide. Knowing the real percentages and what to expect can help you make an informed decision about whether this treatment is right for you.

How Common Are Semaglutide Side Effects in Clinical Trials

Clinical studies tracking semaglutide users have documented the frequency of adverse events across different dose levels and patient populations. In the STEP trials—the major clinical research behind Ozempic and Wegovy—gastrointestinal side effects were the most commonly reported issues. Nausea occurred in approximately 25% to 33% of participants taking semaglutide, making it the most prevalent side effect experienced during treatment.

Vomiting affected about 7% to 11% of trial participants, while diarrhea or constipation each occurred in roughly 20% to 23% of users. These percentages varied depending on the dose strength and how long participants had been on the medication. Most side effects were mild to moderate in severity and decreased over time as the body adapted to the treatment. Severe or persistent side effects that forced people to stop treatment were uncommon, occurring in less than 5% of study participants.

Why Nausea and Digestive Issues Happen with GLP-1 Medications

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that controls appetite and blood sugar levels in your digestive system and brain. When you start taking semaglutide, your stomach processes food more slowly—a process called delayed gastric emptying. This slower movement of food through your digestive tract is what creates feelings of fullness and reduces hunger, but it also triggers nausea, bloating, and changes in bowel habits during the adjustment period.

Your gastrointestinal tract contains millions of GLP-1 receptors, and semaglutide stimulates these receptors directly in your stomach and intestines. This activation can cause temporary inflammation or sensitivity in your gut lining, leading to nausea and digestive discomfort. The good news is that most people's bodies adapt within 4 to 8 weeks as these receptors become less reactive to the medication. Gradual dose increases—starting low and going slow—significantly reduce the intensity and duration of side effects.

Who Is More Likely to Experience Severe Side Effects

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Age, stomach motility issues, and previous medication sensitivities also influence side effect frequency. People over 65, those with a history of gastroparesis, or those prone to motion sickness tend to report more gastrointestinal symptoms when starting semaglutide. Previous rapid dose escalation without a gradual titration schedule is one of the strongest predictors of severe nausea and vomiting. Starting at the lowest effective dose and increasing slowly over weeks or months reduces adverse event rates significantly.

Managing and Minimizing Semaglutide Side Effects

The most effective strategy for reducing side effects is starting with the lowest available dose and increasing gradually based on tolerance and weight loss progress. PlexusDx's Microdose GLP-1 Protocol (available at $129/mo) uses lower initial doses to minimize nausea while still activating weight loss pathways. Eating smaller, more frequent meals—especially avoiding high-fat or high-fiber foods during the first weeks—can significantly reduce nausea and bloating. Staying well-hydrated, eating slowly, and avoiding carbonated beverages also help your stomach adapt more comfortably.

Most gastrointestinal side effects resolve naturally within 4 to 12 weeks without additional medication as your body develops tolerance. If nausea persists beyond this window, your PlexusDx care provider can adjust your dose, switch to oral semaglutide, or explore alternative compounds like tirzepatide. Ginger supplements, peppermint tea, and taking your injection on the evening before a light meal day can provide additional relief. Staying active with light exercise and managing stress through meditation or breathing exercises also improves digestive comfort during the adjustment phase.

Compounded Semaglutide Versus Brand-Name Ozempic: Side Effect Profiles

Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as brand-name Ozempic, meaning the side effect profile is virtually identical. The difference lies in cost and accessibility: PlexusDx's compounded semaglutide injection starts at just $189/mo (or $149/mo on the 6-month plan), compared to $900–$1,400 per month for Ozempic without insurance. Both versions go through the same injection process, activate the same GLP-1 receptors in your body, and produce the same nausea, vomiting, and constipation rates during the dose-titration phase.

Clinical research consistently shows that compounded medications from licensed 503A pharmacies perform identically to brand-name versions in terms of efficacy and side effects. The medication molecules are chemically identical, so your body processes them the same way. The main advantage of choosing compounded semaglutide is that PlexusDx's personalized dosing protocols and genetic testing help you minimize side effects more effectively. With the Precision Peptide Genetic Test ($298), you can identify your genetic risk factors for severe side effects before they start, allowing your provider to choose the best dose escalation schedule for your unique genetics.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What percentage of people experience nausea from semaglutide?

Approximately 25% to 33% of people taking semaglutide report nausea during clinical trials. The majority of these cases are mild to moderate and resolve within 4 to 8 weeks as your body adapts. Starting with a low dose and increasing gradually is the most effective way to minimize nausea intensity.

How long do semaglutide side effects typically last?

Most gastrointestinal side effects peak during the first 2 to 4 weeks and improve significantly by 8 to 12 weeks. Some people experience lingering constipation or mild nausea beyond this timeframe, but severe symptoms that require medication discontinuation are uncommon. PlexusDx providers monitor your adaptation and adjust dosing based on your individual response.

Can I prevent side effects before starting semaglutide?

You can reduce side effect severity by starting at the lowest dose, eating smaller meals, staying hydrated, and avoiding high-fat foods during the adjustment phase. PlexusDx's Precision Peptide Genetic Test identifies your genetic predisposition to side effects, allowing your provider to create a personalized dose escalation plan. The Microdose GLP-1 Protocol at $129/mo is specifically designed for people concerned about side effects.

Are side effects from compounded semaglutide different from brand-name Ozempic?

No. Compounded semaglutide from licensed 503A pharmacies has identical side effect rates to Ozempic because the active ingredient is the same. PlexusDx's compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan—significantly less expensive—while maintaining the same safety and efficacy profile. You get the same results for less cost and better personalization through genetic testing.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx's Precision Peptide Genetic Test ($298) analyzes 14 biological pathways and 150+ genetic insights, including key GLP-1 receptor variants that influence medication tolerance and side effect sensitivity. This test helps your provider anticipate which side effects you're more likely to experience and design a dose schedule that minimizes them while maximizing weight loss.

Related Reading

• Ozempic Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.